ATE313332T1 - Chaperonin 10 und beta-interferon therapie für multiple sklerose - Google Patents
Chaperonin 10 und beta-interferon therapie für multiple skleroseInfo
- Publication number
- ATE313332T1 ATE313332T1 AT00903434T AT00903434T ATE313332T1 AT E313332 T1 ATE313332 T1 AT E313332T1 AT 00903434 T AT00903434 T AT 00903434T AT 00903434 T AT00903434 T AT 00903434T AT E313332 T1 ATE313332 T1 AT E313332T1
- Authority
- AT
- Austria
- Prior art keywords
- beta
- multiple sclerosis
- chaperonine
- interferon therapy
- chaperonin
- Prior art date
Links
- 201000006417 multiple sclerosis Diseases 0.000 title abstract 4
- 108090000467 Interferon-beta Proteins 0.000 title abstract 3
- 102000003996 Interferon-beta Human genes 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 102100024341 10 kDa heat shock protein, mitochondrial Human genes 0.000 abstract 2
- 108010059013 Chaperonin 10 Proteins 0.000 abstract 2
- 102100026720 Interferon beta Human genes 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Surgical Instruments (AREA)
- Developing Agents For Electrophotography (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPP8239A AUPP823999A0 (en) | 1999-01-20 | 1999-01-20 | A treatment |
| PCT/AU2000/000032 WO2000043033A1 (en) | 1999-01-20 | 2000-01-20 | CHAPERONIN 10 AND β-INTERFERON THERAPY OF MULTIPLE SCLEROSIS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE313332T1 true ATE313332T1 (de) | 2006-01-15 |
Family
ID=3812443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00903434T ATE313332T1 (de) | 1999-01-20 | 2000-01-20 | Chaperonin 10 und beta-interferon therapie für multiple sklerose |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20090214473A1 (https=) |
| EP (1) | EP1150703B1 (https=) |
| JP (1) | JP4691257B2 (https=) |
| KR (1) | KR100694011B1 (https=) |
| AT (1) | ATE313332T1 (https=) |
| AU (2) | AUPP823999A0 (https=) |
| CA (1) | CA2361081C (https=) |
| DE (1) | DE60024967T2 (https=) |
| DK (1) | DK1150703T3 (https=) |
| ES (1) | ES2255484T3 (https=) |
| PT (1) | PT1150703E (https=) |
| WO (1) | WO2000043033A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070275890A1 (en) * | 2004-01-16 | 2007-11-29 | Johnson Barbara J | Chaperonin 10 Modulation Of Toll-Like Receptor-Inducible Cytokine And Chemokine Secretion |
| BG66458B1 (bg) * | 2005-03-21 | 2014-10-31 | Иван Иванов | Средство за конкурентно инхибиране на ендогенен гама интерферон |
| CN101309934B (zh) | 2005-08-31 | 2014-02-12 | 悉生物有限公司 | 修饰的伴侣蛋白10 |
| JP2009511610A (ja) * | 2005-10-20 | 2009-03-19 | シービーアイオー リミテッド | 過敏症治療 |
| MX2008011167A (es) * | 2006-03-02 | 2008-11-12 | Cbio Ltd | Regulaciòn de respuestas inmunes mediante la modulaciòn de la funciòn de cèlulas presentadoras de antìgenos. |
| BG66517B1 (bg) | 2008-04-08 | 2016-02-29 | Tigo Gmbh | Супресор на ендогенния човешки гама - интерферон |
| US9359421B2 (en) | 2008-04-08 | 2016-06-07 | Tigo Gmbh | Suppressor of the endogenous interferon-gamma |
| BG1430U1 (bg) * | 2010-06-25 | 2011-04-29 | Иван ИВАНОВ | Фармацевтично средство |
| BG67190B1 (bg) | 2017-03-29 | 2020-11-16 | Tigo Gmbh | Анти-гама мутантен протеин срещу ендогенния човешки гама интерферон |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT731811E (pt) * | 1993-11-30 | 2005-04-29 | Univ Queensland | Chaperonina 10 |
| HUT76099A (en) * | 1994-05-10 | 1997-06-30 | Immulogic Pharma Corp | Compositions and treatment for multiple sclerosis |
| DE19544768C1 (de) * | 1995-11-30 | 1997-07-10 | Rentschler Arzneimittel | Verwendung einer Kombination aus Pentoxifyllin mit Typ-I-Interferonen zur Behandlung der Multiplen Sklerose |
-
1999
- 1999-01-20 AU AUPP8239A patent/AUPP823999A0/en not_active Abandoned
-
2000
- 2000-01-20 PT PT00903434T patent/PT1150703E/pt unknown
- 2000-01-20 DE DE60024967T patent/DE60024967T2/de not_active Expired - Lifetime
- 2000-01-20 CA CA2361081A patent/CA2361081C/en not_active Expired - Fee Related
- 2000-01-20 ES ES00903434T patent/ES2255484T3/es not_active Expired - Lifetime
- 2000-01-20 JP JP2000594486A patent/JP4691257B2/ja not_active Expired - Fee Related
- 2000-01-20 EP EP00903434A patent/EP1150703B1/en not_active Expired - Lifetime
- 2000-01-20 WO PCT/AU2000/000032 patent/WO2000043033A1/en not_active Ceased
- 2000-01-20 AU AU25271/00A patent/AU771867B2/en not_active Ceased
- 2000-01-20 DK DK00903434T patent/DK1150703T3/da active
- 2000-01-20 AT AT00903434T patent/ATE313332T1/de not_active IP Right Cessation
- 2000-01-20 KR KR1020017009163A patent/KR100694011B1/ko not_active Expired - Fee Related
-
2009
- 2009-01-29 US US12/362,456 patent/US20090214473A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000043033A1 (en) | 2000-07-27 |
| ES2255484T3 (es) | 2006-07-01 |
| AUPP823999A0 (en) | 1999-02-11 |
| DE60024967D1 (en) | 2006-01-26 |
| KR20020002376A (ko) | 2002-01-09 |
| KR100694011B1 (ko) | 2007-03-12 |
| EP1150703A1 (en) | 2001-11-07 |
| DK1150703T3 (da) | 2006-05-29 |
| EP1150703B1 (en) | 2005-12-21 |
| JP2002535286A (ja) | 2002-10-22 |
| JP4691257B2 (ja) | 2011-06-01 |
| AU771867B2 (en) | 2004-04-01 |
| EP1150703A4 (en) | 2004-11-10 |
| US20090214473A1 (en) | 2009-08-27 |
| DE60024967T2 (de) | 2006-08-17 |
| PT1150703E (pt) | 2006-05-31 |
| AU2527100A (en) | 2000-08-07 |
| CA2361081A1 (en) | 2000-07-27 |
| CA2361081C (en) | 2010-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
| CY1107995T1 (el) | ΑΝΑΣΤΟΛΗ ΔΡΑΣΤΙΚΟΤΗΤΑΣ p38 ΚΙΝΑΣΗΣ ΧΡΗΣΙΜΟΠΟΙΩΝΤΑΣ ΑΡΥΛ ΚΑΙ ΕΤEPΟΑΡΥΛ ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ ΕΤEPΟΚΥΚΛΙΚΕΣ ΟΥΡΙΕΣ | |
| DE69526120D1 (de) | Verwendung von nebivolol als anti-atherogenisches mittel | |
| IL178072A0 (en) | Use of monoesters of probucol or a pharmaceutically acceptable salt thereof for preparing medicaments for the treatment of cardiovascular disease | |
| ES2151467T1 (es) | Inhibicion de la actividad de la quinasa p38 por aril-ureas. | |
| ATE232396T1 (de) | Oxydiertes thymosin beta 4 | |
| UA48946C2 (uk) | Арилалкілдіазинони, спосіб їх одержання (варіанти), фармацевтичний склад, спосіб його одержання та спосіб лікування | |
| HUT76258A (en) | Compositions comprising dna damaging agents and p53, and methods for uses thereof | |
| MX9704030A (es) | 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos. | |
| NO972391D0 (no) | 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav | |
| AR034343A1 (es) | Combinaciones farmaceuticas | |
| DK0500773T3 (da) | Ikke-glycosyleret FGF-4 og præparater indeholdende dette | |
| RU95106680A (ru) | Бициклические ароматические соединения и содержащие их фармацевтические и косметические композиции | |
| ATE82127T1 (de) | N-acetylglucosamin-zubereitungen zur buccalen anwendung. | |
| ATE313332T1 (de) | Chaperonin 10 und beta-interferon therapie für multiple sklerose | |
| GEP20002092B (en) | 5,6-Dihydropyrone Derivatives Pharma¬ceutical Compositions on the Base of them and Method for Treatment of Antiviral diseases | |
| BR9809678A (pt) | Derivados de triptolìdeo úteis no tratamento de doenças autoimunes | |
| EA200000242A1 (ru) | Применение фанхинона для лечения болезни альцгеймера | |
| DE69612056D1 (de) | Terpenderivate (sarcodictyine) als antikrebsmittel | |
| TR199901385T2 (xx) | Piperidin t�revleri. | |
| FI922428A0 (fi) | Nya 2-amino-5-cyan-1,4- dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel. | |
| DE69314586D1 (de) | Arzneimittelzusammensetzung enthaltend TCF-II | |
| TR200003352T2 (tr) | Yeni pentaerythrit türevleri, bunların imalatı ve kullanımları ile bunların sentezi için ara maddeler | |
| SE9902673D0 (sv) | New composition | |
| ES2181160T3 (es) | Derivados de 1,4-dihidropiridina y su utilizacion en terapia. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |